Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker
This article is from
The Cancer Letter
archive.
Vol. 40 No. 37 | October 3, 2014
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Five Year Plan for Cancer centers Called ‘East Bloc ’ Directive
February 2, 1990
TCL Archive
Funding opportunities listed.
March 12, 2004
TCL Archive
Bonadonna’s Study At Four Years: CMF Group Still Doing Better
November 24, 1978
TCL Archive
Drugs and Targets: Cyramza approved in metastatic stomach cancer
November 7, 2014
TCL Archive
INSPIRE Enrollment Stopped; Thromboembolism Risk Cited
February 25, 2011
TCL Archive
Bioassay Backlog To Be Cleared Up In Year: Squire
November 26, 1976